Table of Contents
Volume 1 | Issue 3
Publication Date: December 2002
Abstract
No Access
Pay-Per View
Full Text
Add to Cart
Editorial | ||
 137 |
Editorial Oliver Sartor |
|
Researches in Brief | ||
139-141 |
New Treatment Modalities for Hormone-Resistant Prostate Cancer David Lee, Oliver Sartor |
|
142-144 |
Role of Free Prostate-Specific Antigen Measurement in Prostate-Specific Antigen Screening for Prostate Cancer Lori Johnson, Oliver Sartor, Judd W. Moul, Eric A. Klein |
|
Comprehensive Reviews | ||
145-152 |
Zoledronic Acid Significantly Reduces Pathologic Fractures in Patients with Advanced-Stage Prostate Cancer Metastatic to Bone Fred Saad |
|
153-162 |
National Cancer Institute Intramural Approach to Advanced Prostate Cancer Philip M. Arlen, William D. Figg, James Gulley, Michael C. Cox, W. Marston Linehan, William Dahut |
|
Original Contributions | ||
163-171 |
Intermittent Versus Continuous Total Androgen Blockade in the Treatment of Patients with Advanced, Hormone-Naive Prostate Cancer: Results of a Prospective Randomized Multicenter Trial Jean de Leval, Philippe Boca, Enis Youssef, Hubert Nicolas, Michel Jeukenne, Laurence Seidel, Christian Bouffioux, Luc Coppens, Pierre Bonnet, Robert Andrianne, David Waltregny |
|
172-176 |
The Pursuit of Prostate Cancer in Patients with a Rising Prostate-Specific Antigen and Multiple Negative Transrectal Ultrasound-Guided Prostate Biopsies Michael B. Pryor, Paul F. Schellhammer |
|
Translational Medicine | ||
177-181 |
G Protein–Coupled Receptors Provide Survival Signals in Prostate Cancer Charles W. Yowell, Yehia Daaka |
|
Current Trial | ||
182-187 |
The Design of a Randomized, Placebo-Controlled Trial of Celecoxib in Preprostatectomy Men with Clinically Localized Adenocarcinoma of the Prostate Elisabeth I. Heath, Theodore L. DeWeese, Alan W. Partin, Angelo M. De Marzo, John D. Groopman, William G. Nelson, Steven A. Piantadosi, Ron Lieberman, Michael A. Carducci |
|
